Tuesday, July 25, 2006

Tamoxifen May Only Lengthen Life for Very High Risk Breast Cancer Patients

Most women with an elevated risk for breast cancer will not live longer if they take the cancer prevention drug tamoxifen, a new study shows. Researchers concluded only very high-risk women benefit in terms of life expectancy when they take the drug for prevention. They calculated that women at the lower end of the high-risk scale would spend a whopping $1.3 million per year of life added if they purchased tamoxifen in the United States. In Canada, where the drug sells for much less, the cost per year of life saved was estimated to be about one-tenth that amount. The researchers used a computer-generated model to predict life expectancies for a hypothetical group of women at high risk for breast cancer who did and did not take tamoxifen to lower their risk. --Click the title of this post to read the full article from its source--


Post a Comment

<< Home

/* WebRing Code */